In breast cancer cells, the effects obtained depend not only on the status of estrogen and progesterone receptors (estrogen receptor; ER and progesterone receptor; PR), but also on the specific genetic/epigenetic cellular background. This evidence concerns the gene ESR1 and breast carcinoma.